Immediate Impact
1 from Science/Nature 52 standout
Citing Papers
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2025 Standout
Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines
2025 Standout
Works of Willem Lybaert being referenced
18F-AlF-NOTA-Octreotide Outperforms68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study
2022
Bilateral Corneal Graft Rejection Associated With Pembrolizumab Treatment
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Willem Lybaert | 138 | 47 | 74 | 86 | 30 | 370 | |
| Genevieve Lyons | 60 | 54 | 111 | 45 | 24 | 392 | |
| Shun C. Young | 116 | 52 | 53 | 61 | 18 | 382 | |
| Luisa Ricaurte | 97 | 34 | 62 | 167 | 25 | 357 | |
| Leanne Goldstein | 103 | 14 | 37 | 48 | 21 | 315 | |
| Fabio Marazzi | 145 | 13 | 73 | 90 | 47 | 371 | |
| L Larrodera | 128 | 42 | 31 | 75 | 20 | 405 | |
| Snehal G. Thakkar | 137 | 41 | 46 | 197 | 18 | 411 | |
| Janusz J. Szymendera | 165 | 20 | 31 | 75 | 40 | 374 | |
| Alessandra Mele | 56 | 36 | 54 | 35 | 28 | 318 | |
| Takeshi Fujita | 52 | 37 | 30 | 67 | 47 | 404 |
All Works
Login with ORCID to disown or claim papers
Loading papers...